KineMed Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Technologies
  • Pharmaceuticals
See more in Biomedtracker

Latest on KineMed Inc.

In Vivo

Execs On The Move, July-August 2014

Company Changes New At The Helm This Month ADAMS , Jason To: Epic Sciences Inc. , VP, Bus. Dev. (May) From: Ventana Medical Systems Inc., Companion Diagnostics Bus. Dev. Group Phone: 858-356-66

Medtech Insight

Medtech Execs On The Move, June-July 2014

Company Changes ADAMS , Jason To: Epic Sciences Inc. , VP, Bus. Dev. (May) From: Ventana Medical Systems Inc., Companion Diagnostics Bus. Dev. Group Phone: 858-356-6610 CHACKO , Jacob, MD To:

Pink Sheet

Nascent Sarcopenia Pipeline’s First Target Is Myostatin

 
• By Bridget Silverman

The emerging sarcopenia pipeline has advanced to Phase II, led by monoclonal antibody candidates that block activation of proteins associated with skeletal muscle loss. Novartis AG , Eli Lilly &

Pink Sheet

Catalyzing Sarcopenia Drug Development: Identifying Outcomes, Defining Disease

 
• By Bridget Silverman

Lack of an accepted disease definition and outcome measures have held back R&D efforts in frailty and sarcopenia, but collaborative public/private efforts have recently made strides that could catalyz